The Motley Fool
08 Jul 2026, 01:53 UTC · 3h ago
Why Eli Lilly Stock Climbed to a Record High Today
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
The Motley Fool
08 Jul 2026, 01:53 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
JPMorgan analyst Chris Schott raised the price target for Eli Lilly from $1,300 to $1,400 and reiterated an overweight rating. — Price target increases from a major investment bank typically trigger immediate upward price movement and attract institutional buyers.
+0.60JPMorgan expects Eli Lilly's second-quarter earnings, reporting August 5, to exceed consensus estimates. — Expectations of an earnings beat create positive sentiment and anticipation for a catalyst event in early August.
+0.50The new GLP-1 Bridge program has made Zepbound and Foundayo available to eligible Medicare patients for as low as $50 per month. — Increased accessibility to high-demand obesity drugs for a potential pool of 20 million Medicare patients suggests a significant expansion of the addressable market.
+0.40Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
Shares hit an all-time high following a price target increase and upbeat analyst remarks regarding its GLP-1 drug success.
Mentioned as the source of the analysis and an advertising partner without specific positive or negative operational news.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
The Motley Fool
2h ago
